1 – 10 of 307
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The Paintings Reveal the Story : Case Study of a Well-Known Swedish Artist Suffering from Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology : a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial
(
- Contribution to journal › Article
-
Mark
AβPP-tau-HAS1 axis trigger HAS1-related nuclear speckles and gene transcription in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests
2024) In Nature Medicine(
- Contribution to journal › Article
-
Mark
Extracellular Vesicles Slow Down Aβ(1−42) Aggregation by Interfering with the Amyloid Fibril Elongation Step
(
- Contribution to journal › Article
-
Mark
Prognostic and Predictive Factors in Early Alzheimer's Disease : A Systematic Review
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Sex differences in disease progression in Alzheimer patients with different concomitant medications.
2023) 17th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2023)(
- Contribution to conference › Abstract
-
Mark
Endocannabinoid System Biomarkers in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Neuroinflammation and amyloid-β in early Alzheimer’s disease. Insight into the earliest events using mouse models
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers
(
- Contribution to journal › Article